(PharmaNewsWire.Com, March 14, 2019 ) The patient engagement technology market is expected to grow rapidly as the healthcare industry witnesses a shift to a value-based reimbursement system from the traditional volume-based fee for reimbursement system. Adoption of patient engagement technology enables the healthcare industry to reduce costs while improving the quality of healthcare. The technology also provides positive returns on investment. Furthermore, legislative reforms of the Affordable Care Act (ACA) in the U.S., government incentives, and rising aging population has stimulated the adoption of patient engagement technology in the healthcare industry. However, in spite of numerous benefits, certain barriers such as huge investments requirement, fragmented end-user market, and security of patient data are restraining the growth of this market.
The study provides granular information regarding pricing of patient engagement technology with breakdown into various cost components. The report also provides insights on replacement market for patient engagement technology; this market presents significant opportunity for vendors in the market due to poor usability of current patient engagement technology.
The research findings cited in the report encapsulates the buying behavior of hospitals for patient engagement technology. It analyses hospitals buying behavior taking into account the size of the hospital and considering the role of key stakeholders in the hospital. Selection criteria considered by providers for embracing patient engagement technology is also included in the scope of the study. A separate section on assessment of lucrative end-user segments is a value-add for the report as well as for its stakeholders. The report also analyzes at length vendor replacement trends and the implementation status (2015) of mobile technology used for patient engagement against various applications.
As the market is patient driven; favourable patient experience plays a critical role in successful patient engagement. However, majority of patient engagement technology fail to deliver a positive patient experience and there have been numerous complaints from patient population regarding the same, which in turn has triggered providers to replace their current vendors. Thus, replacement market for patient engagement technologies offers significant opportunity for vendors in the market due to poor usability of current patient engagement technologies.
The selection of a patient engagement technology must be made based on the organization’s strategic plan and objectives for implementation. Goals and desired outcomes of patient engagement technologies will vary among organizations, from meeting the Meaningful Use incentive to increasing patient engagement. The report enlightens the vendors offering patient engagement technologies about the critical factors that providers perceive as most important and which factors are relatively less important from them.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
